logo

Anaptysbio Inc (ANAB)



Trade ANAB now with
  Date
  Headline
9/28/2018 4:07:28 PM AnaptysBio Announces Closing Of Public Offering
9/25/2018 8:45:46 PM AnaptysBio Announces Pricing Of Underwritten Public Offering Of 2.20 Mln Shares At $94.46/shr
9/24/2018 4:03:56 PM AnaptysBio Announces Proposed Public Offering Of Common Stock
9/24/2018 6:34:22 AM AnaptysBio Reports Positive Topline Data From Phase 2a Proof-of-Concept Clinical Trial Of Etokimab
9/18/2018 6:49:58 AM Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Outperform With $138 Price Target
8/8/2018 10:14:03 AM Wedbush Is Raising ANAPTYSBIO INC (ANAB) FY18 Estimate To -2.45 From -2.98
8/8/2018 10:13:44 AM Wedbush Is Raising ANAPTYSBIO INC (ANAB) Q4 18 Estimate To -0.65 From -0.86
8/8/2018 10:13:21 AM Wedbush Is Raising ANAPTYSBIO INC (ANAB) Q3 18 Estimate To -0.60 From -0.79
8/7/2018 6:39:19 AM AnaptysBio Q2 Loss Per Share $0.57 Vs Loss $0.13 Last Year
4/4/2018 7:05:48 AM RBC Capital Markets Cuts ANAPTYSBIO INC (ANAB) To SectorPerform From Outperform With $86 Down From $144 Price Target
3/27/2018 7:22:29 AM Wedbush Reiterates ANAPTYSBIO INC (ANAB) At Outperform With $151 Price Target
3/6/2018 7:22:05 AM Wedbush Is Cutting ANAPTYSBIO INC (ANAB) FY18 Estimate To -2.02 From -1.88